RecruitingNot ApplicableNCT05882643

Deep Neuromuscular Blockade in Strabismus Surgery

The Effect of the Deep Neuromuscular Block on the Refraction and the Oculocardiac Reflex During Strabismus Surgery in Pediatric Patients - a Prospective Randomized Controlled Trial


Sponsor

Seoul National University Hospital

Enrollment

204 participants

Start Date

Aug 28, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to determine if inducing a moderate or greater neuromuscular block (TOF count 0-3) when performing a neuromuscular block in pediatric patients aged 3 to 18 years undergoing strabismus surgery under general anesthesia can reduce the incidence of the oculocardiac reflex.


Eligibility

Min Age: 3 YearsMax Age: 18 Years

Inclusion Criteria1

  • Pediatric patients between the ages of 3 and 18 who are American Society of Anesthesiologists physical classification (ASA) I, II, or III scheduled for strabismus surgery under general anesthesia.

Exclusion Criteria4

  • Patients with underlying cardiovascular disease
  • Patients with preoperative electrocardiograms showing conduction disturbances
  • Patients with neuromuscular disease
  • Any other patient who, in the opinion of the investigator, is not a good candidate for the study.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERmoderate to deep neuromuscular blockade

* Maintaining moderate to deep neuromuscular blockade during an intraoperative period (Train-of-four 0-3 count, post-tetanic count \> 1) * Rocuronium (intravenous, 1.0 mg/kg at induction period)

OTHERshallow to minimal neuromuscular blockade

* Maintaining shallow to minimal neuromuscular blockade during an intraoperative period (Train-of-four 4, post-tetanic count \< 0.9) * Rocuronium (intravenous, 0.3 mg/kg at induction period)


Locations(1)

Seoul National University Hospital

Seoul, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05882643


Related Trials